Listed

Macrogenics Inc

MGNXNasdaqCIK 1125345HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$32.8m, Q2 FY2026
Operating income−$13.9m, Q2 FY2026
Net income$19.5m, Q2 FY2026
Macrogenics Inc, income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m10.4Revenue, Q3 FY2023, three months to 2023-09-30$10.4m. XBRL concept us-gaap:Revenues. 10-Q filed 2024-11-05, accession 0001125345-24-000160.Report this figure10.7Revenue, Q4 FY2023, three months to 2023-12-31$10.7m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-09, accession 0001125345-26-000017. Derived: 12-month figure less the 9-month figure.Report this figure9.1Revenue, Q1 FY2024, three months to 2024-03-31$9.1m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-05-13, accession 0001125345-25-000053.Report this figure10.8Revenue, Q2 FY2024, three months to 2024-06-30$10.8m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-08-14, accession 0001125345-25-000101.Report this figure111Revenue, Q3 FY2024, three months to 2024-09-30$110.7m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-12, accession 0001125345-25-000108.Report this figure19.4Revenue, Q4 FY2024, three months to 2024-12-31$19.4m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-09, accession 0001125345-26-000017. Derived: 12-month figure less the 9-month figure.Report this figure13.2Revenue, Q1 FY2025, three months to 2025-03-31$13.2m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-13, accession 0001125345-26-000038.Report this figure6.9Revenue, Q2 FY2025, three months to 2025-06-30$6.9m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-14, accession 0001125345-26-000056.Report this figure72.8Revenue, Q3 FY2025, three months to 2025-09-30$72.8m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-12, accession 0001125345-25-000108.Report this figure41.2Revenue, Q4 FY2025, three months to 2025-12-31$41.2m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-09, accession 0001125345-26-000017. Derived: 12-month figure less the 9-month figure.Report this figure20.8Revenue, Q1 FY2026, three months to 2026-03-31$20.8m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-13, accession 0001125345-26-000038.Report this figure32.8Revenue, Q2 FY2026, three months to 2026-06-30$32.8m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-14, accession 0001125345-26-000056.Report this figure
Cost of revenue$m0.1Cost of revenue, Q3 FY2023, three months to 2023-09-30$85.0k. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2024-11-05, accession 0001125345-24-000160.Report this figure0.2Cost of revenue, Q4 FY2023, three months to 2023-12-31$163.0k. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-03-09, accession 0001125345-26-000017. Derived: 12-month figure less the 9-month figure.Report this figure0.3Cost of revenue, Q1 FY2024, three months to 2024-03-31$270.0k. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-05-13, accession 0001125345-25-000053.Report this figure0.2Cost of revenue, Q2 FY2024, three months to 2024-06-30$176.0k. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-08-14, accession 0001125345-25-000101.Report this figure0.2Cost of revenue, Q3 FY2024, three months to 2024-09-30$168.0k. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-11-12, accession 0001125345-25-000108.Report this figure0.2Cost of revenue, Q4 FY2024, three months to 2024-12-31$233.0k. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-03-09, accession 0001125345-26-000017. Derived: 12-month figure less the 9-month figure.Report this figure0.0Cost of revenue, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-05-13, accession 0001125345-25-000053.Report this figure0.0Cost of revenue, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-08-14, accession 0001125345-25-000101.Report this figure0.0Cost of revenue, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-11-12, accession 0001125345-25-000108.Report this figure0.0Cost of revenue, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-03-09, accession 0001125345-26-000017. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reported
Research and development$m30.1Research and development, Q3 FY2023, three months to 2023-09-30$30.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-05, accession 0001125345-24-000160.Report this figure47.4Research and development, Q4 FY2023, three months to 2023-12-31$47.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-09, accession 0001125345-26-000017. Derived: 12-month figure less the 9-month figure.Report this figure46.0Research and development, Q1 FY2024, three months to 2024-03-31$46.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-13, accession 0001125345-25-000053.Report this figure51.7Research and development, Q2 FY2024, three months to 2024-06-30$51.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-14, accession 0001125345-25-000101.Report this figure40.5Research and development, Q3 FY2024, three months to 2024-09-30$40.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-12, accession 0001125345-25-000108.Report this figure38.9Research and development, Q4 FY2024, three months to 2024-12-31$38.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-09, accession 0001125345-26-000017. Derived: 12-month figure less the 9-month figure.Report this figure39.7Research and development, Q1 FY2025, three months to 2025-03-31$39.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-13, accession 0001125345-26-000038.Report this figure40.8Research and development, Q2 FY2025, three months to 2025-06-30$40.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-14, accession 0001125345-26-000056.Report this figure32.7Research and development, Q3 FY2025, three months to 2025-09-30$32.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-12, accession 0001125345-25-000108.Report this figure34.0Research and development, Q4 FY2025, three months to 2025-12-31$34.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-09, accession 0001125345-26-000017. Derived: 12-month figure less the 9-month figure.Report this figure35.0Research and development, Q1 FY2026, three months to 2026-03-31$35.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-13, accession 0001125345-26-000038.Report this figure38.8Research and development, Q2 FY2026, three months to 2026-06-30$38.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-14, accession 0001125345-26-000056.Report this figure
Operating income$m(35.5)Operating income, Q3 FY2023, three months to 2023-09-30−$35.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-05, accession 0001125345-24-000160.Report this figure(49.4)Operating income, Q4 FY2023, three months to 2023-12-31−$49.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-09, accession 0001125345-26-000017. Derived: 12-month figure less the 9-month figure.Report this figure(53.8)Operating income, Q1 FY2024, three months to 2024-03-31−$53.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-13, accession 0001125345-25-000053.Report this figure(58.2)Operating income, Q2 FY2024, three months to 2024-06-30−$58.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-14, accession 0001125345-25-000101.Report this figure54.2Operating income, Q3 FY2024, three months to 2024-09-30$54.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-12, accession 0001125345-25-000108.Report this figure(52.8)Operating income, Q4 FY2024, three months to 2024-12-31−$52.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-09, accession 0001125345-26-000017. Derived: 12-month figure less the 9-month figure.Report this figure(42.6)Operating income, Q1 FY2025, three months to 2025-03-31−$42.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-13, accession 0001125345-26-000038.Report this figure(43.2)Operating income, Q2 FY2025, three months to 2025-06-30−$43.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-14, accession 0001125345-26-000056.Report this figure18.6Operating income, Q3 FY2025, three months to 2025-09-30$18.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-12, accession 0001125345-25-000108.Report this figure(12.1)Operating income, Q4 FY2025, three months to 2025-12-31−$12.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-09, accession 0001125345-26-000017. Derived: 12-month figure less the 9-month figure.Report this figure(33.4)Operating income, Q1 FY2026, three months to 2026-03-31−$33.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-13, accession 0001125345-26-000038.Report this figure(13.9)Operating income, Q2 FY2026, three months to 2026-06-30−$13.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-14, accession 0001125345-26-000056.Report this figure
Interest expense$m0.0Interest expense, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-11-05, accession 0001125345-24-000160.Report this figure0.0Interest expense, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:InterestExpense. 10-K filed 2025-03-20, accession 0001125345-25-000042. Derived: 12-month figure less the 9-month figure.Report this figure1.1Interest expense, Q1 FY2024, three months to 2024-03-31$1.1m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-05-13, accession 0001125345-25-000053.Report this figure0.0Interest expense, Q2 FY2024, three months to 2024-06-30$6.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-08-14, accession 0001125345-25-000101.Report this figure0.0Interest expense, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-11-12, accession 0001125345-25-000108.Report this figure(0.0)Interest expense, Q4 FY2024, three months to 2024-12-31−$24.0k. XBRL concept us-gaap:InterestExpense. 10-K filed 2025-03-20, accession 0001125345-25-000042. Derived: 12-month figure less the 9-month figure.Report this figure0.1Interest expense, Q1 FY2025, three months to 2025-03-31$91.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-05-13, accession 0001125345-26-000038.Report this figure0.8Interest expense, Q2 FY2025, three months to 2025-06-30$802.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-08-14, accession 0001125345-26-000056.Report this figure3.3Interest expense, Q3 FY2025, three months to 2025-09-30$3.3m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-11-12, accession 0001125345-25-000108.Report this figure4.3Interest expense, Q4 FY2025, three months to 2025-12-31$4.3m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-03-09, accession 0001125345-26-000017. Derived: 12-month figure less the 9-month figure.Report this figure4.9Interest expense, Q1 FY2026, three months to 2026-03-31$4.9m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-05-13, accession 0001125345-26-000038.Report this figure4.4Interest expense, Q2 FY2026, three months to 2026-06-30$4.4m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-08-14, accession 0001125345-26-000056.Report this figure
Income tax$mnot reportednot reportednot reported0.0Income tax, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-14, accession 0001125345-25-000101.Report this figure0.0Income tax, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-12, accession 0001125345-25-000108.Report this figure0.9Income tax, Q4 FY2024, three months to 2024-12-31$944.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-09, accession 0001125345-26-000017. Derived: 12-month figure less the 9-month figure.Report this figurenot reported0.1Income tax, Q2 FY2025, three months to 2025-06-30$105.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-14, accession 0001125345-26-000056.Report this figure0.0Income tax, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-12, accession 0001125345-25-000108.Report this figure(0.8)Income tax, Q4 FY2025, three months to 2025-12-31−$777.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-09, accession 0001125345-26-000017. Derived: 12-month figure less the 9-month figure.Report this figurenot reported0.0Income tax, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-14, accession 0001125345-26-000056.Report this figure
Net income$m17.6Net income, Q3 FY2023, three months to 2023-09-30$17.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-05, accession 0001125345-24-000160.Report this figure(46.1)Net income, Q4 FY2023, three months to 2023-12-31−$46.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-09, accession 0001125345-26-000017. Derived: 12-month figure less the 9-month figure.Report this figure(52.2)Net income, Q1 FY2024, three months to 2024-03-31−$52.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001125345-25-000108.Report this figure(55.7)Net income, Q2 FY2024, three months to 2024-06-30−$55.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001125345-25-000108.Report this figure56.3Net income, Q3 FY2024, three months to 2024-09-30$56.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001125345-25-000108.Report this figure(15.4)Net income, Q4 FY2024, three months to 2024-12-31−$15.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-09, accession 0001125345-26-000017. Derived: 12-month figure less the 9-month figure.Report this figure(41.0)Net income, Q1 FY2025, three months to 2025-03-31−$41.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-14, accession 0001125345-26-000056.Report this figure(36.3)Net income, Q2 FY2025, three months to 2025-06-30−$36.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-14, accession 0001125345-26-000056.Report this figure16.8Net income, Q3 FY2025, three months to 2025-09-30$16.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001125345-25-000108.Report this figure(14.2)Net income, Q4 FY2025, three months to 2025-12-31−$14.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-09, accession 0001125345-26-000017. Derived: 12-month figure less the 9-month figure.Report this figure(36.8)Net income, Q1 FY2026, three months to 2026-03-31−$36.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-14, accession 0001125345-26-000056.Report this figure19.5Net income, Q2 FY2026, three months to 2026-06-30$19.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-14, accession 0001125345-26-000056.Report this figure
Diluted EPS$ per share0.28Diluted EPS, Q3 FY2023, three months to 2023-09-30$0.28 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-05, accession 0001125345-24-000160.Report this figurenot reported(0.84)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.84 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-13, accession 0001125345-25-000053.Report this figure(0.89)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.89 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-14, accession 0001125345-25-000101.Report this figure0.90Diluted EPS, Q3 FY2024, three months to 2024-09-30$0.90 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-12, accession 0001125345-25-000108.Report this figurenot reported(0.65)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.65 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-13, accession 0001125345-26-000038.Report this figure(0.57)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.57 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-14, accession 0001125345-26-000056.Report this figure0.27Diluted EPS, Q3 FY2025, three months to 2025-09-30$0.27 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-12, accession 0001125345-25-000108.Report this figurenot reported(0.58)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.58 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-13, accession 0001125345-26-000038.Report this figure0.31Diluted EPS, Q2 FY2026, three months to 2026-06-30$0.31 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-14, accession 0001125345-26-000056.Report this figure
Basic EPS$ per share0.28Basic EPS, Q3 FY2023, three months to 2023-09-30$0.28 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-05, accession 0001125345-24-000160.Report this figurenot reported(0.84)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.84 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-13, accession 0001125345-25-000053.Report this figure(0.89)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.89 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-14, accession 0001125345-25-000101.Report this figure0.90Basic EPS, Q3 FY2024, three months to 2024-09-30$0.90 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-12, accession 0001125345-25-000108.Report this figurenot reported(0.65)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.65 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-13, accession 0001125345-26-000038.Report this figure(0.57)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.57 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-14, accession 0001125345-26-000056.Report this figure0.27Basic EPS, Q3 FY2025, three months to 2025-09-30$0.27 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-12, accession 0001125345-25-000108.Report this figurenot reported(0.58)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.58 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-13, accession 0001125345-26-000038.Report this figure0.31Basic EPS, Q2 FY2026, three months to 2026-06-30$0.31 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-14, accession 0001125345-26-000056.Report this figure

Balance sheet

Cash and equivalents$113.9m, Q2 FY2026
Shareholders' equity$42.9m, Q2 FY2026
Macrogenics Inc, balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m89.9Cash and equivalents, Q3 FY2023, at 2023-09-30$89.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-06, accession 0001125345-23-000124.Report this figure101Cash and equivalents, FY2023, at 2023-12-31$101.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-20, accession 0001125345-25-000042.Report this figure80.4Cash and equivalents, Q1 FY2024, at 2024-03-31$80.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-09, accession 0001125345-24-000088.Report this figure83.9Cash and equivalents, Q2 FY2024, at 2024-06-30$83.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-06, accession 0001125345-24-000148.Report this figure180Cash and equivalents, Q3 FY2024, at 2024-09-30$179.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-05, accession 0001125345-24-000160.Report this figure183Cash and equivalents, FY2024, at 2024-12-31$182.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-09, accession 0001125345-26-000017.Report this figure146Cash and equivalents, Q1 FY2025, at 2025-03-31$145.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-13, accession 0001125345-25-000053.Report this figure131Cash and equivalents, Q2 FY2025, at 2025-06-30$130.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-14, accession 0001125345-25-000101.Report this figure80.1Cash and equivalents, Q3 FY2025, at 2025-09-30$80.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-12, accession 0001125345-25-000108.Report this figure57.2Cash and equivalents, FY2025, at 2025-12-31$57.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-14, accession 0001125345-26-000056.Report this figure66.5Cash and equivalents, Q1 FY2026, at 2026-03-31$66.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-13, accession 0001125345-26-000038.Report this figure114Cash and equivalents, Q2 FY2026, at 2026-06-30$113.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-14, accession 0001125345-26-000056.Report this figure
Current assets$m291Current assets, Q3 FY2023, at 2023-09-30$291.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-06, accession 0001125345-23-000124.Report this figure251Current assets, FY2023, at 2023-12-31$251.3m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-20, accession 0001125345-25-000042.Report this figure203Current assets, Q1 FY2024, at 2024-03-31$202.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-09, accession 0001125345-24-000088.Report this figure157Current assets, Q2 FY2024, at 2024-06-30$157.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-06, accession 0001125345-24-000148.Report this figure222Current assets, Q3 FY2024, at 2024-09-30$222.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-05, accession 0001125345-24-000160.Report this figure217Current assets, FY2024, at 2024-12-31$217.5m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-09, accession 0001125345-26-000017.Report this figure182Current assets, Q1 FY2025, at 2025-03-31$182.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-13, accession 0001125345-25-000053.Report this figure205Current assets, Q2 FY2025, at 2025-06-30$204.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-14, accession 0001125345-25-000101.Report this figure232Current assets, Q3 FY2025, at 2025-09-30$232.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-12, accession 0001125345-25-000108.Report this figure220Current assets, FY2025, at 2025-12-31$219.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-14, accession 0001125345-26-000056.Report this figure183Current assets, Q1 FY2026, at 2026-03-31$182.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-13, accession 0001125345-26-000038.Report this figure322Current assets, Q2 FY2026, at 2026-06-30$321.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-14, accession 0001125345-26-000056.Report this figure
Total assets$m340Total assets, Q3 FY2023, at 2023-09-30$340.0m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-06, accession 0001125345-23-000124.Report this figure298Total assets, FY2023, at 2023-12-31$298.4m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-20, accession 0001125345-25-000042.Report this figure248Total assets, Q1 FY2024, at 2024-03-31$248.3m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-09, accession 0001125345-24-000088.Report this figure201Total assets, Q2 FY2024, at 2024-06-30$201.1m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-06, accession 0001125345-24-000148.Report this figure264Total assets, Q3 FY2024, at 2024-09-30$264.5m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-05, accession 0001125345-24-000160.Report this figure262Total assets, FY2024, at 2024-12-31$261.7m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-09, accession 0001125345-26-000017.Report this figure225Total assets, Q1 FY2025, at 2025-03-31$224.6m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-13, accession 0001125345-25-000053.Report this figure245Total assets, Q2 FY2025, at 2025-06-30$245.4m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-14, accession 0001125345-25-000101.Report this figure271Total assets, Q3 FY2025, at 2025-09-30$270.8m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-12, accession 0001125345-25-000108.Report this figure257Total assets, FY2025, at 2025-12-31$256.8m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-14, accession 0001125345-26-000056.Report this figure218Total assets, Q1 FY2026, at 2026-03-31$217.9m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-13, accession 0001125345-26-000038.Report this figure345Total assets, Q2 FY2026, at 2026-06-30$345.4m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-14, accession 0001125345-26-000056.Report this figure
Current liabilities$m51.3Current liabilities, Q3 FY2023, at 2023-09-30$51.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-06, accession 0001125345-23-000124.Report this figure56.1Current liabilities, FY2023, at 2023-12-31$56.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-20, accession 0001125345-25-000042.Report this figure55.8Current liabilities, Q1 FY2024, at 2024-03-31$55.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-09, accession 0001125345-24-000088.Report this figure57.9Current liabilities, Q2 FY2024, at 2024-06-30$57.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-06, accession 0001125345-24-000148.Report this figure59.3Current liabilities, Q3 FY2024, at 2024-09-30$59.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-05, accession 0001125345-24-000160.Report this figure55.5Current liabilities, FY2024, at 2024-12-31$55.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-09, accession 0001125345-26-000017.Report this figure55.4Current liabilities, Q1 FY2025, at 2025-03-31$55.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-13, accession 0001125345-25-000053.Report this figure39.0Current liabilities, Q2 FY2025, at 2025-06-30$39.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-14, accession 0001125345-25-000101.Report this figure44.5Current liabilities, Q3 FY2025, at 2025-09-30$44.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-12, accession 0001125345-25-000108.Report this figure43.1Current liabilities, FY2025, at 2025-12-31$43.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-14, accession 0001125345-26-000056.Report this figure95.9Current liabilities, Q1 FY2026, at 2026-03-31$95.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-13, accession 0001125345-26-000038.Report this figure109Current liabilities, Q2 FY2026, at 2026-06-30$108.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-14, accession 0001125345-26-000056.Report this figure
Total liabilities$m146Total liabilities, Q3 FY2023, at 2023-09-30$146.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-06, accession 0001125345-23-000124.Report this figure146Total liabilities, FY2023, at 2023-12-31$145.8m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-20, accession 0001125345-25-000042.Report this figure142Total liabilities, Q1 FY2024, at 2024-03-31$142.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-09, accession 0001125345-24-000088.Report this figure143Total liabilities, Q2 FY2024, at 2024-06-30$143.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-06, accession 0001125345-24-000148.Report this figure144Total liabilities, Q3 FY2024, at 2024-09-30$144.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-05, accession 0001125345-24-000160.Report this figure146Total liabilities, FY2024, at 2024-12-31$145.6m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-09, accession 0001125345-26-000017.Report this figure145Total liabilities, Q1 FY2025, at 2025-03-31$145.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-13, accession 0001125345-25-000053.Report this figure199Total liabilities, Q2 FY2025, at 2025-06-30$198.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-14, accession 0001125345-25-000101.Report this figure204Total liabilities, Q3 FY2025, at 2025-09-30$203.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-12, accession 0001125345-25-000108.Report this figure201Total liabilities, FY2025, at 2025-12-31$201.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-14, accession 0001125345-26-000056.Report this figure197Total liabilities, Q1 FY2026, at 2026-03-31$196.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-13, accession 0001125345-26-000038.Report this figure303Total liabilities, Q2 FY2026, at 2026-06-30$302.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-14, accession 0001125345-26-000056.Report this figure
Shareholders' equity$m194Shareholders' equity, Q3 FY2023, at 2023-09-30$194.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2023-11-06, accession 0001125345-23-000124.Report this figure153Shareholders' equity, FY2023, at 2023-12-31$152.6m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-09, accession 0001125345-26-000017.Report this figure106Shareholders' equity, Q1 FY2024, at 2024-03-31$106.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-05-09, accession 0001125345-24-000088.Report this figure57.8Shareholders' equity, Q2 FY2024, at 2024-06-30$57.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-08-06, accession 0001125345-24-000148.Report this figure120Shareholders' equity, Q3 FY2024, at 2024-09-30$120.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-05, accession 0001125345-24-000160.Report this figure116Shareholders' equity, FY2024, at 2024-12-31$116.1m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-09, accession 0001125345-26-000017.Report this figure79.1Shareholders' equity, Q1 FY2025, at 2025-03-31$79.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-05-13, accession 0001125345-25-000053.Report this figure46.6Shareholders' equity, Q2 FY2025, at 2025-06-30$46.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-08-14, accession 0001125345-25-000101.Report this figure67.0Shareholders' equity, Q3 FY2025, at 2025-09-30$67.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001125345-25-000108.Report this figure55.6Shareholders' equity, FY2025, at 2025-12-31$55.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-14, accession 0001125345-26-000056.Report this figure21.2Shareholders' equity, Q1 FY2026, at 2026-03-31$21.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-05-13, accession 0001125345-26-000038.Report this figure42.9Shareholders' equity, Q2 FY2026, at 2026-06-30$42.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-14, accession 0001125345-26-000056.Report this figure

Cash flow

Operating cash flow−$40.7m, Q2 FY2026
Capital expenditure$806.0k, Q2 FY2026
Macrogenics Inc, cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(35.2)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$35.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-05, accession 0001125345-24-000160. Derived: 9-month figure less the 6-month figure.Report this figure(28.0)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$28.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-09, accession 0001125345-26-000017. Derived: 12-month figure less the 9-month figure.Report this figure(45.6)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$45.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-13, accession 0001125345-25-000053.Report this figure(44.5)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$44.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-14, accession 0001125345-25-000101. Derived: 6-month figure less the 3-month figure.Report this figure60.2Operating cash flow, Q3 FY2024, three months to 2024-09-30$60.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-12, accession 0001125345-25-000108. Derived: 9-month figure less the 6-month figure.Report this figure(38.4)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$38.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-09, accession 0001125345-26-000017. Derived: 12-month figure less the 9-month figure.Report this figure(46.9)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$46.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-13, accession 0001125345-26-000038.Report this figure(47.0)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$47.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-14, accession 0001125345-26-000056. Derived: 6-month figure less the 3-month figure.Report this figure(30.2)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$30.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-12, accession 0001125345-25-000108. Derived: 9-month figure less the 6-month figure.Report this figure43.0Operating cash flow, Q4 FY2025, three months to 2025-12-31$43.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-09, accession 0001125345-26-000017. Derived: 12-month figure less the 9-month figure.Report this figure(35.8)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$35.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-13, accession 0001125345-26-000038.Report this figure(40.7)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$40.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-14, accession 0001125345-26-000056. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.5Capital expenditure, Q3 FY2023, three months to 2023-09-30$499.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-05, accession 0001125345-24-000160. Derived: 9-month figure less the 6-month figure.Report this figure0.6Capital expenditure, Q4 FY2023, three months to 2023-12-31$620.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-09, accession 0001125345-26-000017. Derived: 12-month figure less the 9-month figure.Report this figure1.5Capital expenditure, Q1 FY2024, three months to 2024-03-31$1.5m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-13, accession 0001125345-25-000053.Report this figure1.0Capital expenditure, Q2 FY2024, three months to 2024-06-30$1.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-14, accession 0001125345-25-000101. Derived: 6-month figure less the 3-month figure.Report this figure0.6Capital expenditure, Q3 FY2024, three months to 2024-09-30$592.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-12, accession 0001125345-25-000108. Derived: 9-month figure less the 6-month figure.Report this figure0.6Capital expenditure, Q4 FY2024, three months to 2024-12-31$620.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-09, accession 0001125345-26-000017. Derived: 12-month figure less the 9-month figure.Report this figure0.5Capital expenditure, Q1 FY2025, three months to 2025-03-31$529.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-13, accession 0001125345-26-000038.Report this figure0.7Capital expenditure, Q2 FY2025, three months to 2025-06-30$715.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-14, accession 0001125345-26-000056. Derived: 6-month figure less the 3-month figure.Report this figure0.4Capital expenditure, Q3 FY2025, three months to 2025-09-30$426.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-12, accession 0001125345-25-000108. Derived: 9-month figure less the 6-month figure.Report this figure0.2Capital expenditure, Q4 FY2025, three months to 2025-12-31$244.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-09, accession 0001125345-26-000017. Derived: 12-month figure less the 9-month figure.Report this figure0.3Capital expenditure, Q1 FY2026, three months to 2026-03-31$344.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-13, accession 0001125345-26-000038.Report this figure0.8Capital expenditure, Q2 FY2026, three months to 2026-06-30$806.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-14, accession 0001125345-26-000056. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)63.59m, Q2 FY2026
Macrogenics Inc, shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares61.5Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3061,459,831 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-06, accession 0001125345-23-000124.Report this figure61.8Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3161,809,817 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-09, accession 0001125345-24-000088.Report this figure62.3Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3062,261,646 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-06, accession 0001125345-24-000148.Report this figure62.2Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3062,244,602 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-05, accession 0001125345-24-000160.Report this figure62.3Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3162,290,538 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-13, accession 0001125345-25-000053.Report this figure62.7Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3062,663,677 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-14, accession 0001125345-25-000101.Report this figure62.9Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3062,865,841 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-12, accession 0001125345-25-000108.Report this figure63.0Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3162,965,415 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-13, accession 0001125345-26-000038.Report this figure63.1Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3063,136,057 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-14, accession 0001125345-26-000056.Report this figure63.3Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3063,283,624 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-12, accession 0001125345-25-000108.Report this figure63.4Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3163,449,780 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-13, accession 0001125345-26-000038.Report this figure63.6Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3063,594,453 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-14, accession 0001125345-26-000056.Report this figure

Shares outstanding: 63.70mShares outstanding, period not labelled, at 2026-08-0863,700,187 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-14, accession 0001125345-26-000056.Report this figure at Aug 8, 2026, from the cover of the 10-Q filed Aug 14, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:34 ET. Listed shows no prices and gives no investment advice.